1 unchanged sentence
Form of Plan of Conversion (incorporated by reference to Exhibit 2.1 to the Company’s Registration Statement on Form S-1/A filed with the SEC on September 12, 2017).
−Removed: Certificate of Incorporation of the Company, as amended.
+Added: of Incorporation of the Company, as amended.
Bylaws, incorporated by reference from Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 13, 2017.
6 unchanged sentences
Form of Warrant, incorporated by reference from Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the SEC on April 8, 2021.
+Added: First Amendment to Representative’s Warrant, dated September 13, 2022, between Celcuity Inc.
+Added: and Craig Hallum Capital Group, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on September 14, 2022.
Equity Grant Agreement, dated April 8, 2021, between the Company and Pfizer, Inc., incorporated by reference from Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 8, 2021.
2 unchanged sentences
Certificate of Designations of Preferences, Rights and Limitations of Series A Convertible Preferred Stock filed May 16, 2022, incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the SEC on May 18, 2022.
−Removed: Securities Purchase Agreement, dated May 15, 2022, by and among the Company and the Purchasers named therein, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 18, 2022.
−Removed: Registration Rights Agreement, dated May 15, 2022, by and among the Company and the Purchasers named therein, incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on May 18, 2022.
+Added: Third Amendment to Lease, dated July 27, 2022, by and between Celcuity Inc.
+Added: and West Glen Development I, LLC, incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on July 29, 2022.
+Added: The First Amendment to Loan and Security Agreement, dated August 9, 2022, by and among the Company and Innovatus Life Sciences Lending Fund I, LP, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on August 11, 2022.
Certification
6 unchanged sentences
of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: statements from the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2022, formatted in Inline XBRL:
−Removed: the Condensed Balance Sheets, (ii) the Condensed Statements of Operations, (iii) the Condensed Statements of Changes in Stockholders’
−Removed: Equity, (iv) the Condensed Statements of Cash Flows, and (v) the Notes to Condensed Financial Statements.
+Added: statements from the Quarterly Report on Form 10-Q of the Company for the quarter ended September
+Added: 30, 2022, formatted in Inline XBRL:
+Added: (i) the Condensed Balance Sheets, (ii) the Condensed
+Added: Statements of Operations, (iii) the Condensed Statements of Changes in Stockholders’
+Added: Equity, (iv) the Condensed Statements of Cash Flows, and (v) the Notes to Condensed Financial
Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
1 unchanged sentence
the undersigned thereunto duly authorized.
−Removed: August 12, 2022
−Removed: CELCUITY INC.
+Added: November 10, 2022
and Chief Executive Officer
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.